{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:43:31Z","timestamp":1791215011448,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to evaluate the risk of vascular complications of impaired fasting glucose (IFG). This population-based study included 425,608 participants from the National Health Screening Cohort in Korea in 2003 and 2004 who were followed-up until 2015. The participants were classified into normal, IFG, and diabetes groups based on fasting plasma glucose levels. Incidence rate (per 1000 person-year) was evaluated for the following vascular complications: cardiovascular (ischemic heart disease, cerebrovascular disease, arterial and capillary disease), renal, and retinal diseases. Hazard ratios (HR) of IFG for diabetes were estimated after adjusting for patient characteristics. Among the 88,330 IFG participants, the incidence of cardiovascular, chronic renal and retinal diseases were 11.52, 0.47, and 1.08 per 1000 person-years, respectively. Furthermore, IFG patients with a family history of diabetes, past history of hypertension, and high body mass index had significantly increased risk of vascular complications [adjusted HR, cardiovascular: 1.39 (95% CI 1.33\u20131.46); renal: 2.17 (95% CI 1.66\u20132.83); and retinal: 1.14 (95% CI 0.98\u20131.32)]. IFG patients have a substantial risk of cardiovascular, chronic renal and retinal diseases. Therefore, early preventative interventions are beneficial, especially for those with high-risk factors, in whom should emphasize on maintaining a healthy lifestyle, early screening and continuous follow-up.<\/jats:p>","DOI":"10.1038\/s41598-020-76661-7","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T11:03:08Z","timestamp":1605092588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Incidence and risk factors of vascular complications in people with impaired fasting glucose: a national cohort study in Korea"],"prefix":"10.1038","volume":"10","author":[{"given":"Eun Sun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Chul","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"76661_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2013.11.001","volume":"138","author":"N Cho","year":"2018","unstructured":"Cho, N. et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. 138, 271\u2013281. https:\/\/doi.org\/10.1016\/j.diabres.2013.11.001 (2018).","journal-title":"Diabetes Res. Clin."},{"issue":"Supplement1","key":"76661_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc19-S012","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. Standards of medical care in diabetes 2019. Diabetes Care 42(Supplement1), S13\u2013S28. https:\/\/doi.org\/10.2337\/dc19-S012 (2019).","journal-title":"Diabetes Care"},{"issue":"1","key":"76661_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13104-017-2571-3","volume":"10","author":"A Worede","year":"2017","unstructured":"Worede, A., Alemu, S., Gelaw, Y. A. & Abebe, M. The prevalence of impaired fasting glucose and undiagnosed diabetes mellitus and associated risk factors among adults living in a rural Koladiba town, northwest Ethiopia. BMC Res. Notes. 10(1), 251. https:\/\/doi.org\/10.1186\/s13104-017-2571-3 (2017).","journal-title":"BMC Res. Notes."},{"issue":"10","key":"76661_CR4","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2337\/diacare.25.10.1845","volume":"25","author":"JB Meigs","year":"2002","unstructured":"Meigs, J. B., Nathan, D., D\u2019Agostino, R. B. & Wilson, P. W. Fasting and postchallenge glycemia and cardiovascular disease risk: The Framingham Offspring Study. Diabetes Care 25(10), 1845\u20131850. https:\/\/doi.org\/10.2337\/diacare.25.10.1845 (2002).","journal-title":"Diabetes Care"},{"issue":"5","key":"76661_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/dci18-0007","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Economic costs of diabetes in the US in 2017. Diabetes Care 41(5), 917\u2013928. https:\/\/doi.org\/10.2337\/dci18-0007 (2018).","journal-title":"Diabetes Care"},{"issue":"3","key":"76661_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jacc.2007.09.038","volume":"51","author":"YS Levitzky","year":"2008","unstructured":"Levitzky, Y. S. et al. Impact of impaired fasting glucose on cardiovascular disease: The Framingham Heart Study. J. Am. Coll. Cardiol. 51(3), 264\u2013270. https:\/\/doi.org\/10.1016\/j.jacc.2007.09.038 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"76661_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","volume":"26","author":"MJ Fowler","year":"2008","unstructured":"Fowler, M. J. Microvascular and macrovascular complications of diabetes. Clin. Diabetes. 26(2), 77\u201382. https:\/\/doi.org\/10.2337\/diaclin.26.2.77 (2008).","journal-title":"Clin. Diabetes."},{"issue":"13","key":"76661_CR8","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","volume":"6","author":"BM Leon","year":"2015","unstructured":"Leon, B. M. & Maddox, T. M. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J. Diabetes. 6(13), 1246. https:\/\/doi.org\/10.4239\/wjd.v6.i13.1246 (2015).","journal-title":"World J. Diabetes."},{"issue":"1","key":"76661_CR9","doi-asserted-by":"publisher","first-page":"e000254","DOI":"10.1136\/bmjdrc-2016-000254","volume":"4","author":"E Forssas","year":"2016","unstructured":"Forssas, E. et al. Multiple complications among people with diabetes from Finland: An 18-year follow-up in 1994\u20132011. BMJ Open Diabetes Res. Care. 4(1), e000254. https:\/\/doi.org\/10.1136\/bmjdrc-2016-000254 (2016).","journal-title":"BMJ Open Diabetes Res. Care."},{"issue":"20","key":"76661_CR10","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1001\/jama.292.20.2495","volume":"292","author":"CS Fox","year":"2004","unstructured":"Fox, C. S. et al. Trends in cardiovascular complications of diabetes. JAMA 292(20), 2495\u20132499. https:\/\/doi.org\/10.1001\/jama.292.20.2495 (2004).","journal-title":"JAMA"},{"issue":"9","key":"76661_CR11","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/dme.14058","volume":"36","author":"S Bain","year":"2019","unstructured":"Bain, S. et al. Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: An expert consensus in the UK. Diabet. Med. 36(9), 1063\u20131071. https:\/\/doi.org\/10.1111\/dme.14058 (2019).","journal-title":"Diabet. Med."},{"key":"76661_CR12","doi-asserted-by":"publisher","first-page":"e2016004","DOI":"10.4178\/epih\/e2016004","volume":"38","author":"F Mehravar","year":"2016","unstructured":"Mehravar, F. et al. Associations between diabetes self-management and microvascular complications in patients with type 2 diabetes. Epidemiol. Health. 38, e2016004. https:\/\/doi.org\/10.4178\/epih\/e2016004 (2016).","journal-title":"Epidemiol. Health."},{"issue":"43","key":"76661_CR13","first-page":"739","volume":"40","author":"Centers for Disease Control (CDC)","year":"1991","unstructured":"Centers for Disease Control (CDC). Sensitivity of death certificate data for monitoring diabetes mortality\u2014diabetic eye disease follow-up study, 1985\u20131990. MMWR Morb. Mortal. Wkly. Rep. 40(43), 739 (1991).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"11","key":"76661_CR14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2522\/ptj.20080008","volume":"88","author":"WT Cade","year":"2008","unstructured":"Cade, W. T. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys. Ther. 88(11), 1322\u20131335. https:\/\/doi.org\/10.2522\/ptj.20080008 (2008).","journal-title":"Phys. Ther."},{"issue":"13","key":"76661_CR15","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jacc.2009.10.060","volume":"55","author":"ES Ford","year":"2010","unstructured":"Ford, E. S., Zhao, G. & Li, C. Pre-diabetes and the risk for cardiovascular disease: A systematic review of the evidence. J Am Coll Cardiol. 55(13), 1310\u20131317. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.060 (2010).","journal-title":"J Am Coll Cardiol."},{"issue":"7","key":"76661_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2011.08.080","volume":"59","author":"SM Grundy","year":"2012","unstructured":"Grundy, S. M. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J. Am. Coll. Cardiol. 59(7), 635\u2013643. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.080 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"76661_CR17","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV17014","author":"N Katakami","year":"2017","unstructured":"Katakami, N. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J. Atheroscler. Thromb. https:\/\/doi.org\/10.5551\/jat.RV17014 (2017).","journal-title":"J. Atheroscler. Thromb."},{"issue":"4","key":"76661_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","volume":"49","author":"AS Gami","year":"2007","unstructured":"Gami, A. S. et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49(4), 403\u2013414. https:\/\/doi.org\/10.1016\/j.jacc.2006.09.032 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"76661_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12872-016-0230-6","volume":"16","author":"T Namekata","year":"2016","unstructured":"Namekata, T. et al. Estimating the extent of subclinical arteriosclerosis of persons with prediabetes and diabetes mellitus among Japanese urban workers and their families: a cross-sectional study. BMC Cardiovasc. Disord. 16(1), 52. https:\/\/doi.org\/10.1186\/s12872-016-0230-6 (2016).","journal-title":"BMC Cardiovasc. Disord."},{"key":"76661_CR20","unstructured":"World Health orgarnization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO\/IDF consultation. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/43588\/9241594934_eng.pdf. Accessed 4 June 2020 (2006)."},{"issue":"7","key":"76661_CR21","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2337\/dc07-1707","volume":"31","author":"RJ Tapp","year":"2008","unstructured":"Tapp, R. J. et al. Longitudinal association of glucose metabolism with retinopathy: Results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 31(7), 1349\u20131354. https:\/\/doi.org\/10.2337\/dc07-1707 (2008).","journal-title":"Diabetes Care"},{"issue":"12","key":"76661_CR22","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.2337\/diabetes.52.12.2867","volume":"52","author":"JR Singleton","year":"2003","unstructured":"Singleton, J. R., Smith, A. G., Russell, J. W. & Feldman, E. L. Microvascular complications of impaired glucose tolerance. Diabetes 52(12), 2867\u20132873. https:\/\/doi.org\/10.2337\/diabetes.52.12.2867 (2003).","journal-title":"Diabetes"},{"issue":"2","key":"76661_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.12861\/jrip.2013.24","volume":"2","author":"H Shahbazian","year":"2013","unstructured":"Shahbazian, H. & Rezaii, I. Diabetic kidney disease; Review of the current knowledge. J. Ren. Inj. Prev. 2(2), 7. https:\/\/doi.org\/10.12861\/jrip.2013.24 (2013).","journal-title":"J. Ren. Inj. Prev."},{"issue":"4","key":"76661_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2215\/CJN.07891109","volume":"5","author":"LC Plantinga","year":"2010","unstructured":"Plantinga, L. C. et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin. J. Am. Soc. Nephrol. 5(4), 673\u2013682. https:\/\/doi.org\/10.2215\/CJN.07891109 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"76661_CR25","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.2337\/diacare.28.10.2436","volume":"28","author":"CS Fox","year":"2005","unstructured":"Fox, C. S. et al. Glycemic status and development of kidney disease: The Framingham Heart Study. Diabetes Care 28(10), 2436\u20132440. https:\/\/doi.org\/10.2337\/diacare.28.10.2436 (2005).","journal-title":"Diabetes Care"},{"issue":"1","key":"76661_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1471-2369-14-253","volume":"14","author":"Y Zhou","year":"2013","unstructured":"Zhou, Y. et al. Prevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China. BMC Nephrol. 14(1), 253. https:\/\/doi.org\/10.1186\/1471-2369-14-253 (2013).","journal-title":"BMC Nephrol."},{"issue":"8","key":"76661_CR27","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.ophtha.2006.02.052","volume":"113","author":"R Kawasaki","year":"2006","unstructured":"Kawasaki, R. et al. Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: The Funagata Study. Ophthalmology 113(8), 1378\u20131384. https:\/\/doi.org\/10.1016\/j.ophtha.2006.02.052 (2006).","journal-title":"Ophthalmology"},{"issue":"8","key":"76661_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1463-1326.2007.00759","volume":"10","author":"M Tyrberg","year":"2008","unstructured":"Tyrberg, M., Melander, A., L\u00f6vestam-Adrian, M. & Lindblad, U. Retinopathy in subjects with impaired fasting glucose: The NANSY-Eye baseline report. Diabetes Obes. Metab. 10(8), 646\u2013651. https:\/\/doi.org\/10.1111\/j.1463-1326.2007.00759 (2008).","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"76661_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1001\/archopht.121.2.245","volume":"121","author":"HA van Leiden","year":"2003","unstructured":"van Leiden, H. A. et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: The Hoorn study. Arch. Ophthalmol. 121(2), 245\u2013251. https:\/\/doi.org\/10.1001\/archopht.121.2.245 (2003).","journal-title":"Arch. Ophthalmol."},{"issue":"6","key":"76661_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11892-010-0147-x","volume":"10","author":"A Doria","year":"2010","unstructured":"Doria, A. Genetics of diabetes complications. Curr. Diab. Rep. 10(6), 467\u2013475. https:\/\/doi.org\/10.1007\/s11892-010-0147-x (2010).","journal-title":"Curr. Diab. Rep."},{"issue":"11","key":"76661_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/qjmed\/hcp121","volume":"102","author":"S Song","year":"2009","unstructured":"Song, S. & Hardisty, C. Early onset type 2 diabetes mellitus: A harbinger for complications in later years\u2014clinical observation from a secondary care cohort. QJM 102(11), 799\u2013806. https:\/\/doi.org\/10.1093\/qjmed\/hcp121 (2009).","journal-title":"QJM"},{"issue":"5","key":"76661_CR32","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2337\/db16-1150","volume":"66","author":"Q Qi","year":"2017","unstructured":"Qi, Q. et al. Genetics of type 2 diabetes in US Hispanic\/Latino indiiduals: Results from the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL). Diabetes 66(5), 1419\u20131425. https:\/\/doi.org\/10.2337\/db16-1150 (2017).","journal-title":"Diabetes"},{"issue":"1","key":"76661_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.1019","volume":"44","author":"YS Cho","year":"2012","unstructured":"Cho, Y. S. et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat. Genet. 44(1), 67. https:\/\/doi.org\/10.1038\/ng.1019 (2012).","journal-title":"Nat. Genet."},{"key":"76661_CR34","first-page":"153","volume-title":"The Genetics of Type 2 Diabetes and Related Traits","author":"C Jose","year":"2016","unstructured":"Jose, C. & Florez, J. C. The Genetics of Type 2 Diabetes and Related Traits 153\u2013180 (Springer International Publishing, Switzerland, 2016)."},{"key":"76661_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2018\/8964027","volume":"2018","author":"S Cheema","year":"2018","unstructured":"Cheema, S. et al. Risk factors for microvascular complications of diabetes in a high-risk middle east population. J. Diabetes Res. 2018, 7. https:\/\/doi.org\/10.1155\/2018\/8964027 (2018).","journal-title":"J. Diabetes Res."},{"issue":"Supplement 1","key":"76661_CR36","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care 36(Supplement 1), S11\u2013S66. https:\/\/doi.org\/10.2337\/dc13-S011 (2013).","journal-title":"Diabetes Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76661-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:45:51Z","timestamp":1670366751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76661-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76661"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76661-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19504"}}